SCHEMBL23201840

SCHEMBL23201840

COC(=O)C(Cc1ccc(C(F)(F)F)cc1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.58
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
ALDH1A1 P00352 4/20 0.52
GAA P10253 2/20 0.52
HSD11B1 P28845 1/20 0.52
POLB P06746 4/20 0.51
KMT2A Q03164 3/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
NOS2 P35228 1/20 0.46
MEN1 O00255 2/20 0.46
TP53 P04637 1/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21501021 1.00 MAPT (0.58) MAPTNPC1RAB9ASMN1; SMN2CYP2C9
SCHEMBL23201794 0.89 ALDH1A1 (0.51) MAPTNPC1RAB9ASMN1; SMN2CYP2C9
SCHEMBL23201795 0.89 ALDH1A1 (0.51) MAPTNPC1RAB9ASMN1; SMN2CYP2C9
SCHEMBL21501014 0.86 ALDH1A1 (0.56) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL21501052 0.86 HSD11B1 (0.67) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL19597541 0.86 ALDH1A1 (0.70) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL19597540 0.86 ALDH1A1 (0.70) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL21501050 0.84 ALDH1A1 (0.56) MAPTNPC1RAB9ACYP2C9CYP2C19
SCHEMBL21501019 0.84 ALDH1A1 (0.56) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL1597751 0.84 ALDH1A1 (0.57) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3805237-B1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND JIANGSU CHUANGTE PHARMACEUTICAL TECH CO LTD (CN) 2026-01-28 EP disclosed
CN-115785137-A Synthesis and application of peptide borate compound 江苏正大丰海制药有限公司 2023-03-14 CN disclosed
US-11542283-B2 Synthesis of peptide borate ester compound and use thereof JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2023-01-03 US disclosed
CN-112384519-B Synthesis and application of peptide borate compound 江苏正大丰海制药有限公司 2022-11-25 CN disclosed
US-20210214377-A1 SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2021-07-15 US disclosed
EP-3805237-A1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CN) 2021-04-14 EP disclosed
CN-112384519-A Synthesis and application of peptide borate compound 江苏正大丰海制药有限公司 2021-02-19 CN disclosed
CN-110540547-A Synthesis and application of peptide borate compound QIN YANRU 2019-12-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214377-A1 SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF SEM1, VIP, PSMB11 MAPT 2853/4885NPC1 1679/4885RAB9A 2078/4885
US-11542283-B2 Synthesis of peptide borate ester compound and use thereof SEM1, VIP, PSMB11 MAPT 2853/4885NPC1 1679/4885RAB9A 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.